RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells (Q39653370)

13 September 2017

title

RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells (English)

1 reference

13 September 2017

1 reference

1 reference

HaiBin Zhu

1 reference

13 September 2017

Qiqi Mao

1 reference

13 September 2017

Yiwei Lin

1 reference

13 September 2017

Kai Yang

1 reference

13 September 2017

Liping Xie

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20857345

17 July 2024

publication date

21 September 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s12032-010-9679-9.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S12032-010-9679-9

http://link.springer.com/article/10.1007/s12032-010-9679-9/fulltext.html

17 July 2024

1 reference

https://api.crossref.org/works/10.1007/S12032-010-9679-9

http://link.springer.com/content/pdf/10.1007/s12032-010-9679-9

17 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12032-010-9679-9

17 July 2024

1 reference

13 September 2017

volume

28 Suppl 1

1 reference

13 September 2017

page(s)

S381-7

1 reference

13 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Modulation of poly(ADP-ribosylation) in apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Targeting the PI3K/AKT pathway for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

C-Raf controlled pathways in the protection of tumor cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Mutant p53 protein expression interferes with p53-independent apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Akt in prostate cancer: possible role in androgen-independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9679-9

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

21 January 2018

1 reference

12 December 2020

p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

1 reference

12 December 2020

When mutants gain new powers: news from the mutant p53 field.

1 reference

12 December 2020

Effects of silencing of mutant p53 gene in human lung adenocarcinoma cell line Anip973.

1 reference

12 December 2020

Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice

1 reference

12 December 2020

p53 is mutated in a subset of advanced-stage prostate cancers

1 reference

12 December 2020

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

12 December 2020

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

12 December 2020

Identifiers

DOI

1 reference

13 September 2017

1 reference